These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 303878)

  • 21. CD45+ and CD45- lymphocyte populations identified by flow cytometry from dogs with lymphoma exhibit similar morphology and the same clonal (B cell or T cell) lineage.
    Fogle JE; Tarigo JL; Thalheim L; Williams LE; English LB; Suter SE
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):242-8. PubMed ID: 26553299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid, single step technique for determination of B and T cell surface markers in malignant lymphoid cells.
    Trigg ME; Wesley RA; Holiman BJ; Cole DE; Poplack DG
    Exp Hematol; 1982 Sep; 10(8):668-74. PubMed ID: 6982827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.
    Zwingenberger AL; Kent MS; Shi C; Taylor SL; Chen X; Lam KS
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):298-304. PubMed ID: 22177114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lukes-Collins classification and its significance.
    Lukes RJ; Collins RD
    Cancer Treat Rep; 1977 Sep; 61(6):971-9. PubMed ID: 302740
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
    Babusíková O; Babusík P; Novotná L
    Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic characterization of canine lymphoma, using monoclonal antibodies and a microlymphocytotoxicity assay.
    Ladiges WC; Keast M; Appelbaum F; Storb R
    Am J Vet Res; 1988 Jun; 49(6):870-2. PubMed ID: 3400923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mixed lymphocyte culture. Correlation with PPD skin tests in patients with no-Hodgkin's lymphomata (author's transl)].
    Sasiain MC; Ruibal Ares B; Suárez A; Bachmann AE
    Sangre (Barc); 1979; 24(4):424-30. PubMed ID: 158225
    [No Abstract]   [Full Text] [Related]  

  • 31. T and B lymphocyte enumeration in the diagnosis of lymphocyte-rich pleural fluids.
    Domagała W; Emeson EE; Koss LG
    Acta Cytol; 1981; 25(2):108-10. PubMed ID: 6972683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood lymphocyte subsets in canine idiopathic pericardial effusion.
    Guglielmino R; Miniscalco B; Tarducci A; Borgarelli M; Riondato F; Zini E; Borrelli A; Bussadori C
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):167-73. PubMed ID: 15010225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of therapy on the behavior of T and B-lymphocytes in patients with non-Hodgkin's lymphoma].
    Franke A; Spormann H; Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):872-7. PubMed ID: 6176513
    [No Abstract]   [Full Text] [Related]  

  • 34. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline skin lymphoma: characterization of tumor and identification of tumor-stimulating serum factor(s).
    Legendre AM; Becker PU
    Am J Vet Res; 1979 Dec; 40(12):1805-7. PubMed ID: 316659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-dependent selection of B lymphoma cells varying in Ia density by cloned antigen-specific L3T4a+ T cells: a possible in vitro model for B cell adaptive differentiation.
    Tite JP; Janeway CA
    J Mol Cell Immunol; 1984; 1(4):253-65. PubMed ID: 6336593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma.
    Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Fosmire SP; Coffey D; Bellgrau D; Modiano JF
    Vet Pathol; 2005 Jul; 42(4):468-76. PubMed ID: 16006606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study of non-Hodgkin's lymphoma (author's transl)].
    Kotoo Y
    Fukuoka Igaku Zasshi; 1978 Feb; 69(2):73-82. PubMed ID: 306366
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunophenotypic characterization of canine lymphoproliferative disorders.
    Ruslander DA; Gebhard DH; Tompkins MB; Grindem CB; Page RL
    In Vivo; 1997; 11(2):169-72. PubMed ID: 9179611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.